Access to Medicines in Developing Countries: Ethical Demands and Moral Economy

&
Developing World Bioethics 14 (2):ii-viii (2014)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/dewb.12066

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Rationing the access to high cost medicines in developing countries.Debora Diniz - 2009 - Developing World Bioethics 9 (2):ii-iii.
Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation.Rudolf V. Van Puymbroeck - 2010 - Journal of Law, Medicine and Ethics 38 (3):520-549.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Pharmaceutical companies and access to medicines – social integration and ethical CSR resolution of a global public choice problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Supply of medicines: paternalism, autonomy and reality.D. Prayle & M. Brazier - 1998 - Journal of Medical Ethics 24 (2):93-98.
Access to Medicines and Distributive Justice: Breaching Doha's Ethical Threshold.Rachel Kiddell-Monroe - 2014 - Developing World Bioethics 14 (2):59-66.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
The Ethics of Intellectual Property Rights in an Era of Globalization.Aakash Kaushik Shah, Jonathan Warsh & Aaron S. Kesselheim - 2013 - Journal of Law, Medicine and Ethics 41 (4):841-851.
Pharmaceutical innovation and the burden of disease in developing and developed countries.Frank R. Lichtenberg - 2005 - Journal of Medicine and Philosophy 30 (6):663 – 690.
Improving access to essential medicines: How health concerns can be prioritised in the global governance system.Devi Sridhar - 2008 - Public Health Ethics 1 (2):83-88.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.

Analytics

Added to PP
2014-07-18

Downloads
25 (#616,937)

6 months
4 (#790,687)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

‘Pharmacy of the World’ is ill?Aman Goyal - 2015 - Developing World Bioethics 15 (1):ii-ii.

Add more citations

References found in this work

Bodies of rights and therapeutic markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (2):359-386.

Add more references